We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SANM icon
676
Sanmina
SANM
$11.2B
$547K ﹤0.01%
+4,753
New +$534K
GL icon
677
Globe Life
GL
$13.5B
$546K ﹤0.01%
3,817
-386
-9% -$52.3K
ONTO icon
678
Onto Innovation
ONTO
$13.6B
$543K ﹤0.01%
4,206
-624
-13% -$66.8K
VMI icon
679
Valmont Industries
VMI
$9.44B
$543K ﹤0.01%
1,401
-136
-9% -$49.5K
COCO icon
680
Vita Coco
COCO
$3.77B
$540K ﹤0.01%
12,719
-516
-4% -$19.1K
VLY icon
681
Valley National Bancorp
VLY
$7.93B
$540K ﹤0.01%
+50,945
New +$509K
ACLS icon
682
Axcelis
ACLS
$4.12B
$538K ﹤0.01%
5,513
-2,017
-27% -$162K
UPWK icon
683
Upwork
UPWK
$1.09B
$536K ﹤0.01%
28,847
-2,791
-9% -$41.6K
OZK icon
684
Bank OZK
OZK
$5.49B
$536K ﹤0.01%
+10,506
New +$537K
CORT icon
685
Corcept Therapeutics
CORT
$10.2B
$534K ﹤0.01%
6,426
-137
-2% -$9.91K
PRDO icon
686
Perdoceo Education
PRDO
$1.9B
$531K ﹤0.01%
14,113
-409
-3% -$13.1K
PTCT icon
687
PTC Therapeutics
PTCT
$6.37B
$530K ﹤0.01%
8,632
-925
-10% -$48.2K
AA icon
688
Alcoa
AA
$11.7B
$529K ﹤0.01%
+16,099
New +$501K
JHG
689
DELISTED
Janus Henderson
JHG
$528K ﹤0.01%
11,860
-1,683
-12% -$72.7K
FIX icon
690
Comfort Systems
FIX
$61B
$527K ﹤0.01%
639
-327
-34% -$222K
STRL icon
691
Sterling Infrastructure
STRL
$20.3B
$525K ﹤0.01%
1,547
-808
-34% -$229K
FNB icon
692
FNB Corp
FNB
$6.78B
$525K ﹤0.01%
+32,600
New +$519K
STOK icon
693
Stoke Therapeutics
STOK
$1.82B
$524K ﹤0.01%
22,318
-21,637
-49% -$371K
INVX
694
Innovex International
INVX
$1.87B
$523K ﹤0.01%
28,191
-2,358
-8% -$39.2K
RGLD icon
695
Royal Gold
RGLD
$17.1B
$523K ﹤0.01%
2,605
-28
-1% -$4.84K
VOYA icon
696
Voya Financial
VOYA
$8.94B
$521K ﹤0.01%
+6,967
New +$514K
COLB icon
697
Columbia Banking Systems
COLB
$8.81B
$520K ﹤0.01%
+20,212
New +$513K
POWL icon
698
Powell Industries
POWL
$8.46B
$519K ﹤0.01%
5,109
-2,823
-36% -$239K
GAP
699
The Gap Inc
GAP
$6.84B
$519K ﹤0.01%
24,264
-42
-0.2% -$908
PTGX icon
700
Protagonist Therapeutics
PTGX
$8.75B
$518K ﹤0.01%
7,792
-1,643
-17% -$93.4K

Similar funds

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.